Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Arteriovenous Malformations Market Expected To Expand Between 2025 And 2029?
The arteriovenous malformations market has shown strong expansion in recent years. It is projected to increase from $2.88 billion in 2024 to $3.1 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.7%. This past growth can be attributed to the growing occurrence of arteriovenous malformations, the rising prevalence of neurological or brain disorders, the increasing demand for improved treatments for rare diseases, augmented government support for research and development, and an expanding business sector.
The arteriovenous malformations market is projected to experience substantial expansion over the upcoming years. Its valuation is set to reach $4.1 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.2%. This anticipated growth throughout the forecast period stems from factors such as increasing adoption of gene therapy, escalating demand for sophisticated medical technologies, a greater need for high-quality healthcare services, heightened usage of neurological medications, and the expansion aligned with an aging global populace. Key developments expected during this timeframe encompass progress in various treatment modalities, enhancements in medical technology, refinements in microsurgical approaches, breakthroughs in catheter technology, and improvements in minimally invasive surgical procedures.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21888&type=smp
Which Major Market Drivers Are Shaping The Future Of The Arteriovenous Malformations Market?
The increasing need for minimally invasive medical interventions is anticipated to fuel the expansion of the arteriovenous malformations market in the future. These procedures involve surgical or therapeutic methods conducted through tiny cuts or catheter-based approaches, aiming to lessen physical harm, shorten healing periods, and minimize adverse effects. The growing preference for minimally invasive operations stems from quicker recovery periods, given that they entail smaller incisions, which results in less tissue damage and a faster healing process. Consequently, patients can resume their regular routines sooner than with conventional open surgeries, establishing these procedures as a favored option for both individuals receiving care and medical professionals. Arteriovenous malformations (AVMs) facilitate minimally invasive approaches through sophisticated methods like endovascular embolization. This technique employs catheters and imaging guidance to diminish irregular blood flow, circumventing the necessity for open surgery, thereby resulting in reduced hazards, accelerated recovery, and enhanced patient results. As an illustration, data from the American Society of Plastic Surgeons in September 2023 indicates that in 2023, the total number of cosmetic minimally invasive procedures reached 25,442,640, an increase from 23,672,269 procedures performed in 2022. This signifies a 7% rise in minimally invasive treatments for both sexes during 2023. Thus, the increasing inclination towards minimally invasive procedures is propelling the expansion of the arteriovenous malformations market.
What Are The Primary Types Of Segments Analyzed In The Arteriovenous Malformations Market?
The arteriovenous malformationsmarket covered in this report is segmented –
1) By Type: True Arteriovenous Malformation; Occult Or Cryptic; Cavernous Malformations; Venous Malformation; Hemangioma; Dural Fistula; Other Types
2) By Diagnosis: Physical examination; Brain Scans; Other Diagnosis
3) By Treatment: Endovascular Embolization; Neurosurgery
4) By Age Group: Adult Patients; Pediatric Patients
5) By End-User: Hospitals And Clinics; Research laboratories; Other End-Users
Subsegments:
1) By True Arteriovenous Malformation Type: Pial AVMs; Spinal AVMs; Brain AVMs; Extremity AVMs; Visceral AVMs
2) By Occult or Cryptic Type: Micro-AVMs; Hidden AVMs; Asymptomatic AVMs; Deep-Seated AVMs; Small-Scale AVMs
3) By Cavernous Malformations Type: Cerebral Cavernous Malformations (CCMs); Spinal Cavernous Malformations; Familial Cavernous Malformations; Solitary Cavernous Malformations; Multiple Cavernous Malformations
4) By Venous Malformation Type: Superficial Venous Malformations; Deep Venous Malformations; Mixed Venous Malformations; Syndromic Venous Malformations; Blue Rubber Bleb Nevus Syndrome
5) By Hemangioma Type: Infantile Hemangiomas; Capillary Hemangiomas; Lobular Capillary Hemangiomas; Cavernous Hemangiomas; Compound Hemangiomas
6) By Dural Fistula Type: Cranial Dural Arteriovenous Fistula (dAVF); Spinal Dural Arteriovenous Fistula; Direct Dural AV Fistula; Indirect Dural AV Fistula; High-Flow Dural Fistula
7) By Other Types: Lymphatic Malformations; Mixed Vascular Malformations; Arteriovenous Aneurysms; Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs; Rare Congenital AVMs
Which Trends Are Impacting The Arteriovenous Malformations Market?
Leading companies in the arteriovenous malformations market are prioritizing technological advancements, such as liquid embolic system procedural sets, to improve treatment processes and patient outcomes. A liquid embolic system procedural set is a pre-assembled, sterilized kit containing essential components for delivering liquid embolic agents to treat vascular abnormalities like arteriovenous malformations (AVMs). For example, in March 2024, CERENOVUS Inc., a US-based neurovascular care company under Johnson and Johnson MedTech, introduced the TRUFILL n-BCA liquid embolic system procedural set. This new set comprises two configurations and the necessary accessories for preparing and delivering the n-BCA liquid embolic system within a single sterilized package, thus optimizing procedure preparation for treating cerebral arteriovenous malformations (AVMs).
Who Are The Core Companies Influencing The Arteriovenous Malformations Market Landscape?
Major companies operating in the arteriovenous malformations market are Johnson And Johnson Services Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N V, Stryker Corporation, GE Healthcare Technologies Inc, Cedars-Sinai, Penn Medicine, Terumo Corporation, Eisai Co Ltd, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc., Penumbra Inc., Max Healthcare, RWJBarnabas Health, Balt LLC, Booking Health GmbH, Duke University Health System, Shape Memory Medical Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/arteriovenous-malformations-global-market-report
What Are The Regional Market Dynamics Impacting The Arteriovenous Malformations Industry?
North America was the largest region in the arteriovenous malformations market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriovenous malformations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Arteriovenous Malformations Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21888&type=smp
Browse Through More Reports Similar to the Global Arteriovenous Malformations Market 2025, By The Business Research Company
Animal Hospitals And Veterinary Clinics Market 2025
https://www.thebusinessresearchcompany.com/report/animal-hospitals-and-veterinary-clinics-market
Minimal Invasive Surgery Devices Global Market Report 2025
Small Electrical Appliance Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/small-electrical-appliance-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model